Biological Tissue Covered Self-Expanding Occluder for Biocompatibility

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing occluders for closing the left atrial appendage lack sufficient biocompatibility, which can lead to complications such as thrombus formation and increased risk of stroke.

Innovation Solution

An occluder with a self-expanding frame covered by biological tissue, specifically arranged on the outer side to enhance biocompatibility, is proposed. The biological tissue is stabilized using cross-linking methods and can be animal tissue like pericardium membrane.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of manufacture

If synthetic materials like Teflon are used to cover the occluder frame, then the structural integrity and ease of manufacture are improved, but the biocompatibility deteriorates leading to thrombus formation and stroke risk

Engineering Contradiction:
Improveease of manufactureVSAvoidbiocompatibility
Core Design Contradiction:
Ease of manufactureVSReliability

Solution Approach 1:

The patent applies composite materials by combining the occluder frame with biological tissue (such as pericardium) to create a hybrid structure. The frame provides structural integrity while the biological tissue layer provides biocompatibility, resolving the contradiction between ease of manufacture and reliability. The biological tissue is sutured to the frame to form a composite occluder that combines the advantages of both materials.

Inventive Principle:
Principle #40Composite materials

2Reliability

If biological tissue is used to cover the occluder frame, then the biocompatibility is improved reducing thrombus formation risk, but the manufacturing complexity increases

Engineering Contradiction:
ImprovebiocompatibilityVSAvoiddevice complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent segments the occluder into distinct components: the frame structure and the biological tissue covering. This segmentation allows each component to be manufactured separately using appropriate methods, then assembled together. The frame can be manufactured using standard techniques while the biological tissue is prepared separately and sutured onto the frame, reducing overall manufacturing complexity compared to creating a fully customized biological composite.

Inventive Principle:
Principle #1Segmentation

3Ease of operation

If the occluder is inserted in a volume-reduced form and expanded at the site of use, then the ease of operation is improved allowing catheter delivery, but the manufacturing precision requirements increase

Engineering Contradiction:
Improveease of operationVSAvoidmanufacturing precision
Core Design Contradiction:
Ease of operationVSManufacturing precision

Solution Approach 1:

The patent utilizes parameter changes by designing the occluder frame with shape memory alloy properties that enable it to transition between a compressed delivery state and an expanded functional state. The frame is manufactured in a compressed configuration for easy catheter delivery, then automatically expands to its predetermined functional shape at the insertion site through shape memory effect, eliminating the need for manual expansion while maintaining manufacturing precision.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The use of biological tissue on the occluder significantly improves biocompatibility, reducing the risk of thrombus formation and enhancing the fluid-tight closure of the left atrial appendage, thereby lowering the risk of stroke.

Implementation Method 1

The frame can in particular consist of a flexible, self-expanding material or comprise such a material. This material can be a metal or a plastic. Advantageously, however, it is a metal alloy with shape memory properties. Nickel-titanium alloys, for example a nitinol alloy, are particularly preferred.

Methodology Applied
Scientific EffectShape memory alloy: Shape Memory Alloy

Implementation Method 2

The biological tissue is stabilized, in particular, by treatment using a cross-linking method. Cross-linking can preferably be carried out using the cross-linking process, particularly glutaraldehyde and/or alcohol.

Methodology Applied
Scientific EffectCross-linking: Chemical Bonding

Implementation Method 3

The occluder is delivered to the site of use, in particular in a volume-reduced form, and expanded there. Self-expanding materials, such as shape memory alloys, are generally used for the occluders.

Methodology Applied
Scientific EffectElastic deformation: Elasticity

Data Source

PatentEP4215128B1Occluder, occluder system and insertion catheter, and method for providing system
Publication Date: 2025.06.18 QATNA MEDICAL GMBH
  • EP4215128B1 patent drawingFigure 1
  • EP4215128B1 patent drawingFigure 2
  • EP4215128B1 patent drawingFigure 3

AI summary

Occluder (12), in particular for closing the left auricle of the cord (10) of a patient, system with a catheter and an occluder and method for providing the system, the occluder (12) comprising a self-expanding frame (14), wherein a biological tissue (40) covering at least part of the frame (14), in particular on its outside, is arranged, wherein the biological tissue (40) is stabilized by treatment using a cross-linking method and is moistened or dried with a liquid medium for preservation.